What is DOTS Technology?
DOTS Technology, headquartered in Natick, Massachusetts, is a pioneering diagnostics platform poised to revolutionize point-of-care detection. The company's initial product focuses on identifying the presence of food allergens, addressing a critical need in the food safety and consumer health markets. This innovative approach aims to provide rapid and accurate diagnostic results directly at the point of need.
How much funding has DOTS Technology raised?
DOTS Technology has raised a total of $29.3M across 3 funding rounds:
Series A
$8M
Series B
$20.9M
Debt
$350K
Series A (2015): $8M, investors not publicly disclosed
Series B (2017): $20.9M, investors not publicly disclosed
Debt (2020): $350K supported by PPP
Key Investors in DOTS Technology
PPP
Public-Private Partnership
What's next for DOTS Technology?
With a major enterprise-level funding context and a recent strategic investment, DOTS Technology is positioned for significant scaling and market penetration. The company's focus on diagnostics, particularly in areas like food allergen detection, aligns with growing global demands for enhanced safety and health monitoring. Future developments are likely to involve expanding their product portfolio, enhancing technological capabilities, and forging strategic partnerships to broaden their reach within the healthcare and food industries. This capital infusion will be crucial for accelerating product development, regulatory approvals, and market adoption.
See full DOTS Technology company page
